While we find that anti-CTLA-4 or anti-PD-1 can synergize with neo VAX in different tumor models when we give the first NeoAg vaccine and ICT mAb at the same time, the timing of treatment may impact the response in certain situations, as observed in other models and vaccine settings95. The gene discussed is CTLA4; the disease is neoplasm.